Severin Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Severin Investments's VRTX Position: Q2 2026 in Review
Severin Investments increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, buying an estimated $50.5K and bringing the position to 1,022 shares worth $508K. The position accounts for 0.38% of the portfolio, ranked #93.
Severin Investments first reported a position in VRTX in Q4 2024 and has held it in 5 quarters since. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Severin Investments held 1,022 shares of Vertex Pharmaceuticals worth $508K as of Q2 2026.
- Severin Investments bought 114 Vertex Pharmaceuticals shares in Q2 2026, an estimated $50.5K.
- Vertex Pharmaceuticals made up 0.38% of Severin Investments's portfolio in Q2 2026, its #93 holding.
- Severin Investments first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
- 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.